The patented method uses genetic markers and a weighted algorithm to assess the responsiveness to renal denervation.

About the Paradise Ultrasound Renal Denervation System The Paradise uRDN system is a first-of-its-kind ultrasound-based RDN ...

On Thursday, the US Centers for Medicare & Medicaid Services (CMS) issued its proposal for covering radiofrequency- or ...

Medtronic and Recor Medical both issued statements supporting new Medicare coverage for their respective renal denervation ...

Analysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover ...

Medtronic is studying the use of its nitinol-enabled Symplicity Spyral renal denervation (RDN) catheter combined with hepatic ...

Medtronic reported that it has begun testing an expansion of its renal denervation approach for dropping stubbornly high blood pressure, by also treating vessels outside of the kidneys.&n | The ...

CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...

Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), today announced their support for ...

The Centers for Medicare & Medicaid Services (CMS) issued a proposed decision memo for its National Coverage Analysis (NCA) ...

Finally, recent attempts to evaluate the cost–effectiveness of renal denervation [19, 20] – essentially based on Symplicity HTN-2 – are unlikely to provide reliable information in the ...

Medtronic announced that the first patient has been treated in its SPYRAL GEMINI global pilot study, which will investigate the saf ...